| Fiscal period | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|
| Period End Date | 3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 |
|---|
| Revenues | 359,051.00 | 308,951.00 | 276,711.00 | 263,966.00 | 238,228.00 | 231,051.00 | 214,319.00 | 208,357.00 | 198,533.00 | 190,884.00 |
| Total Revenues | 359,051.00 | 308,951.00 | 276,711.00 | 263,966.00 | 238,228.00 | 231,051.00 | 214,319.00 | 208,357.00 | 198,533.00 | 190,884.00 |
| Cost of sales | 345,728.00 | 296,123.00 | 264,353.00 | 250,836.00 | 226,080.00 | 219,028.00 | 202,565.00 | 197,173.00 | 187,262.00 | 179,468.00 |
| Gross Profit | 13,323.00 | 12,828.00 | 12,358.00 | 13,130.00 | 12,148.00 | 12,023.00 | 11,754.00 | 11,184.00 | 11,271.00 | 11,416.00 |
| Goodwill impairment charge | -- | -- | 0.00 | 0.00 | 69.00 | 2.00 | 1,797.00 | 1,738.00 | 290.00 | -- |
| Research and development | -- | -- | -- | -- | -- | 96.00 | 71.00 | 125.00 | 341.00 | 392.00 |
| Selling | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Distribution | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Administrative | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, Distribution, Research and Development and Administration Expenses | 8,507.00 | 8,657.00 | 7,776.00 | 10,537.00 | 8,849.00 | 9,168.00 | 8,403.00 | 8,138.00 | 7,466.00 | 7,276.00 |
| Restructuring charges | 286.00 | 115.00 | 209.00 | 281.00 | 334.00 | 268.00 | 597.00 | 567.00 | 18.00 | 203.00 |
| Gain (loss) on sales of Business | -- | -- | -- | -- | -- | -- | 0.00 | (109.00) | -- | -- |
| Securities Litigation (charge) credit | -- | -- | -- | -- | (7,936.00) | -- | -- | -- | 6.00 | -- |
| Gain on Healthcare Technology Net Asset Exchange, net | -- | -- | -- | -- | -- | -- | -- | 37.00 | 3,947.00 | -- |
| Claims and litigation charges, net | (108.00) | (147.00) | 8.00 | (274.00) | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | (8,901.00) | (8,919.00) | (7,977.00) | (11,092.00) | (17,188.00) | (9,534.00) | (10,868.00) | 10,422.00 | 4,162.00 | (7,871.00) |
| Operating Income / (Loss) | 4,422.00 | 3,909.00 | 4,381.00 | 2,038.00 | (5,040.00) | 2,489.00 | 886.00 | 762.00 | 7,109.00 | 3,545.00 |
| Interest expense | 265.00 | 252.00 | 248.00 | 178.00 | 217.00 | 249.00 | 264.00 | 283.00 | 308.00 | 353.00 |
| Impairment of an Equity Investment | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain (Loss) on Investments, Net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss from equity method investment in Change Healthcare | -- | -- | -- | 0.00 | 0.00 | (1,108.00) | (194.00) | (248.00) | -- | -- |
| Other income (loss) net | 202.00 | 132.00 | 497.00 | 259.00 | 223.00 | 12.00 | 182.00 | 130.00 | 90.00 | 58.00 |
| Loss on debt extinguishment | -- | 0.00 | 0.00 | (191.00) | -- | 0.00 | 0.00 | (122.00) | -- | -- |
| Income (loss) from continuing operations before income taxes | 4,359.00 | 3,789.00 | 4,630.00 | 1,928.00 | (5,034.00) | 1,144.00 | 610.00 | 239.00 | 6,891.00 | 3,250.00 |
| Current- Foreign | 254.00 | 134.00 | 180.00 | 240.00 | 181.00 | 142.00 | 152.00 | 205.00 | 122.00 | 90.00 |
| Current: Federal | 552.00 | 867.00 | 619.00 | 233.00 | (15.00) | 170.00 | (20.00) | 577.00 | 524.00 | 658.00 |
| Deferred: Federal | 102.00 | (360.00) | (46.00) | 88.00 | (562.00) | (204.00) | 223.00 | (767.00) | 767.00 | 95.00 |
| Deferred: Foreign | (217.00) | (110.00) | (10.00) | (38.00) | (142.00) | (33.00) | (78.00) | (118.00) | (49.00) | (73.00) |
| Current: State and local | 182.00 | 231.00 | 126.00 | 129.00 | 47.00 | 48.00 | 35.00 | 33.00 | 86.00 | 96.00 |
| Deferred: State and Local | 5.00 | (133.00) | 36.00 | (16.00) | (204.00) | (105.00) | 44.00 | 17.00 | 164.00 | 42.00 |
| Provision for Income Taxes | 878.00 | 629.00 | 905.00 | 636.00 | (695.00) | 18.00 | 356.00 | (53.00) | 1,614.00 | 908.00 |
| Continuing operations | 3,481.00 | 3,160.00 | 3,725.00 | 1,292.00 | (4,339.00) | 1,126.00 | 254.00 | 292.00 | 5,277.00 | 2,342.00 |
| Discontinued operations | 0.00 | 0.00 | (3.00) | (5.00) | (1.00) | (6.00) | 1.00 | 5.00 | (124.00) | (32.00) |
| Discontinued operation - gain on sale, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (Loss) | 3,481.00 | 3,160.00 | 3,722.00 | 1,287.00 | (4,340.00) | 1,120.00 | 255.00 | 297.00 | 5,153.00 | 2,310.00 |
| Net loss attributable to noncontrolling interests (7) | 186.00 | 158.00 | 162.00 | 173.00 | 199.00 | 220.00 | 221.00 | 230.00 | 83.00 | 52.00 |
| Dividends on Preferred Securities of Subsidiary Trust, Net of Tax Benefit | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income attributable to common shareholders | 3,295.00 | 3,002.00 | 3,560.00 | 1,114.00 | (4,539.00) | 900.00 | 34.00 | 67.00 | 5,070.00 | 2,258.00 |
| Earnings Per Share (Basic) - Cont Ops | 25.86 | 22.54 | 25.25 | 7.35 | (28.26) | 5.01 | 0.17 | 0.30 | 23.50 | 9.96 |
| EPS (Basic) : Disc Ops | 0.00 | 0.00 | (0.02) | (0.03) | 0.00 | (0.03) | 0.00 | 0.02 | (0.55) | (0.14) |
| Discontinued operation - gain on sale, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | 25.86 | 22.54 | 25.23 | 7.32 | (28.26) | 4.98 | 0.17 | 0.32 | 22.95 | 9.82 |
| Earnings Per Share (Diluted) - Cont Ops | 25.72 | 22.39 | 25.05 | 7.26 | (28.26) | 4.99 | 0.17 | 0.30 | 23.28 | 9.84 |
| Earnings Per Share (Diluted) - Disc Ops | 0.00 | 0.00 | (0.02) | (0.03) | 0.00 | (0.04) | 0.00 | 0.02 | (0.55) | (0.14) |
| Discontinued operation - gain on sale, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Diluted) | 25.72 | 22.39 | 25.03 | 7.23 | (28.26) | 4.95 | 0.17 | 0.32 | 22.73 | 9.70 |
| Weighted average shares basic | 127.40 | 133.20 | 141.10 | 152.30 | 160.60 | 181.00 | 196.00 | 208.00 | 221.00 | 230.00 |
| Weighted average shares diluted | 128.10 | 134.10 | 142.20 | 154.10 | 160.60 | 182.00 | 197.00 | 209.00 | 223.00 | 233.00 |